Amalgamated Bank Xencor Inc Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2025

A detailed history of Amalgamated Bank transactions in Xencor Inc stock. As of the latest transaction made, Amalgamated Bank holds 19,899 shares of XNCR stock, worth $181,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,899

Previous 20,243 1.7%

Holding current value

$181,478

Previous $465,000 54.41%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$10.64 - $24.13 $3,660 - $8,300	-344 Reduced 1.7%	19,899 $212,000
Q4 2024 Feb 04, 2025	BUY	$19.43 - $26.84 $39,404 - $54,431	2,028 Added 11.13%	20,243 $465,000
Q3 2024 Oct 30, 2024	SELL	$15.7 - $21.65 $2,276 - $3,139	-145 Reduced 0.79%	18,215 $366,000
Q2 2024 Aug 12, 2024	SELL	$18.21 - $24.5 $4,042 - $5,439	-222 Reduced 1.19%	18,360 $348,000
Q1 2024 Apr 23, 2024	SELL	$18.65 - $26.52 $108,673 - $154,532	-5,827 Reduced 23.87%	18,582 $411,000
Q4 2023 Feb 06, 2024	SELL	$16.53 - $21.42 $9,670 - $12,530	-585 Reduced 2.34%	24,409 $518,000
Q3 2023 Nov 08, 2023	SELL	$20.08 - $25.39 $14,437 - $18,255	-719 Reduced 2.8%	24,994 $504,000
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $19,543 - $23,591	789 Added 3.17%	25,713 $642,000
Q1 2023 May 02, 2023	SELL	$25.95 - $36.95 $52,159 - $74,269	-2,010 Reduced 7.46%	24,924 $695,000
Q4 2022 Feb 10, 2023	BUY	$24.79 - $30.86 $4,586 - $5,709	185 Added 0.69%	26,934 $701,000
Q3 2022 Nov 09, 2022	BUY	$24.62 - $32.44 $5,711 - $7,526	232 Added 0.87%	26,749 $695,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $36,933 - $54,277	-1,871 Reduced 6.59%	26,517 $726,000
Q1 2022 Jun 30, 2022	SELL	$26.68 - $41.63 $41,327 - $64,484	-1,549 Reduced 5.17%	28,388 $757,000
Q4 2021 Feb 15, 2022	SELL	$33.67 - $43.44 $7,946 - $10,251	-236 Reduced 0.78%	29,937 $1.2 Million
Q3 2021 Oct 29, 2021	SELL	$30.65 - $35.68 $19,003 - $22,121	-620 Reduced 2.01%	30,173 $985,000
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $774,862 - $1.01 Million	22,571 Added 274.52%	30,793 $1.06 Million
Q1 2021 May 13, 2021	SELL	$40.81 - $53.88 $29,750 - $39,278	-729 Reduced 8.14%	8,222 $354,000
Q4 2020 Feb 12, 2021	BUY	$36.63 - $47.63 $5,384 - $7,001	147 Added 1.67%	8,951 $390,000
Q3 2020 Oct 30, 2020	SELL	$30.09 - $43.02 $8,575 - $12,260	-285 Reduced 3.14%	8,804 $342,000
Q2 2020 Aug 10, 2020	BUY	$27.76 - $33.42 $5,968 - $7,185	215 Added 2.42%	9,089 $294,000
Q1 2020 May 13, 2020	SELL	$20.69 - $37.79 $5,565 - $10,165	-269 Reduced 2.94%	8,874 $265,000
Q4 2019 Feb 13, 2020	BUY	$32.75 - $41.43 $11,986 - $15,163	366 Added 4.17%	9,143 $314,000
Q3 2019 Nov 13, 2019	BUY	$33.73 - $46.27 $10,152 - $13,927	301 Added 3.55%	8,777 $296,000
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $39,723 - $54,928	1,342 Added 18.81%	8,476 $347,000
Q1 2019 May 15, 2019	BUY	$27.85 - $38.09 $7,825 - $10,703	281 Added 4.1%	7,134 $222,000
Q4 2018 Feb 15, 2019	BUY	$32.39 - $42.05 $221,968 - $288,168	6,853 New	6,853 $248,000
Q3 2018 Nov 14, 2018	SELL	$35.69 - $47.65 $252,792 - $337,504	-7,083 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$28.41 - $42.41 $201,228 - $300,390	7,083 New	7,083 $262,000

Others Institutions Holding XNCR

# of Institutions

210

Shares Held

78.4M

Call Options Held

3.4K

Put Options Held

1.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $544M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Xencor Inc Transaction History